Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia

被引:52
|
作者
Tooney, PA [1 ]
Chahl, LA
机构
[1] Univ Newcastle, Fac Hlth, Sch Biomed Sci, Newcastle, NSW 2308, Australia
[2] Neurosci Inst Schizophrenia & Allied Disorders, Darlinghurst, NSW, Australia
来源
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2004年 / 28卷 / 02期
基金
澳大利亚国家健康与医学研究理事会;
关键词
calcium-binding proteins; immunohistochemistry; interneurons; prefrontal cortex; schizophrenia;
D O I
10.1016/j.pnpbp.2003.10.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Increased neuronal density, cortical thinning, and alterations of GABAergic interneurons in the prefrontal cortex have been associated with the pathophysiology of schizophrenia. This study used antibodies directed against the calcium-binding proteins, calretinin (CR), parvalbumin (PV), and calbindin (CB) to compare the relative density of subpopulations of GABAergic interneurons in BA9 of the prefrontal cortex from six subjects with schizophrenia and six control subjects matched for age, gender, and postmortem interval. The relative density of interneurons expressing CR, PV, or CB did not differ significantly between subjects with schizophrenia and control subjects. In addition, no change in somal size of immunoreactive (IR) neurons or cortical thickness was observed between the two groups. This study supports previous reports consistently demonstrating no change in the relative density of interneurons expressing CR in the dorsolateral prefrontal cortex in schizophrenia but does not support previous inconsistent findings that the relative density of interneurons expressing PV and CB might be altered in this disorder. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [1] Neurons expressing calcium binding proteins in the prefrontal cortex in psychiatric disorders
    Sakai, T.
    Oshima, A.
    Nakazato, Y.
    Akiyama, H.
    Ikeda, K.
    Mikuni, M.
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 61 (02) : S2 - S2
  • [2] Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins
    Beasley, CL
    Zhang, ZJ
    Patten, I
    Reynolds, GP
    BIOLOGICAL PSYCHIATRY, 2002, 52 (07) : 708 - 715
  • [3] Neuronal calcium-binding proteins and schizophrenia
    Eyles, DW
    McGrath, JJ
    Reynolds, GP
    SCHIZOPHRENIA RESEARCH, 2002, 57 (01) : 27 - 34
  • [4] CALCIUM-BINDING PROTEINS IN APLYSIA NEURONS
    HERMANN, A
    PAULS, TL
    HEIZMANN, CW
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1991, 11 (04) : 371 - 386
  • [5] Effect of juvenile emotional experience on CRF and calcium-binding proteins in the medial prefrontal cortex
    Helmeke, C
    Poeggel, G
    Richter-Levin, G
    Braun, K
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 88 - 88
  • [6] CALCIUM-BINDING PROTEINS AS MARKERS FOR SUBPOPULATIONS OF GABAERGIC NEURONS IN MONKEY STRIATE CORTEX
    VANBREDERODE, JFM
    MULLIGAN, KA
    HENDRICKSON, AE
    JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 298 (01) : 1 - 22
  • [7] Deficits of parvalbumin-expressing neurons in the prefrontal cortex in schizophrenia
    Reynolds, GP
    Beasley, CL
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 75 - 76
  • [8] Calcium-binding proteins are altered in the cerebellum in schizophrenia
    Vidal-Domenech, Francisco
    Riquelme, Gemma
    Pinacho, Raquel
    Rodriguez-Mias, Ricard
    Vera, America
    Monje, Alfonso
    Ferrer, Isidre
    Callado, Luis F.
    Meana, J. Javier
    Villen, Judit
    Ramos, Belen
    PLOS ONE, 2020, 15 (07):
  • [9] Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex
    Zaitsev, AV
    Gonzalez-Burgos, G
    Povysheva, NV
    Kröner, S
    Lewis, DA
    Krimer, LS
    CEREBRAL CORTEX, 2005, 15 (08) : 1178 - 1186
  • [10] GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression
    Grazyna Rajkowska
    Gillian O'Dwyer
    Zsofia Teleki
    Craig A Stockmeier
    Jose Javier Miguel-Hidalgo
    Neuropsychopharmacology, 2007, 32 : 471 - 482